Renal Cell Carcinoma – Epidemiology – Epidemiology Data Slicer

launch Related Market Assessment Reports

• Osteoporosis – Landscape & Forecast – Disease Landscape & Forecast

  September 2023

  With an increasing prevalence owing to aging populations, the major-market osteoporosis patient pool is large and growing. The combined influence of increased patient numbers, increasing uptake of…

• Nonalcoholic Steatohepatitis – Current Treatment – Detailed, Expanded Analysis: Current Treatment: Physician Insights (US)

  September 2023

• Renal Cell Carcinoma – Landscape & Forecast – Disease Landscape & Forecast

  August 2023

  The renal cell carcinoma (RCC) therapy market is rapidly evolving and experiencing substantial growth, largely driven by the increasing uptake of immune checkpoint inhibitors. Combination regimens…

• Breast Cancer – Geographic Focus: China – Breast Cancer – China In-Depth (China)

  July 2023

  Breast cancer is the most prevalent malignancy in women in China. Chemotherapy was the mainstay of treatment, but China now has access to several cutting-edge premium-priced targeted therapies (e.g…

• Non-Small-Cell Lung Cancer – Geographic Focus: China – Non-Small-Cell Lung Cancer – China In-Depth (China)

  June 2023

  Non-small-cell lung cancer (NSCLC)—the primary cause of cancer-related mortality in China—has a very dynamic pipeline that includes numerous targeted and biomarker-driven therapies. Notably,…